Christopher W. Schultz
Impact in
- Oncology top 10%
- Lung Cancer Research Studies
- Pancreatic and Hepatic Oncology Research
- PARP inhibition in cancer therapy
-
- Cancer-related molecular mechanisms research
Papers in
- Oncology 16
- Pancreatic and Hepatic Oncology Research 8
- Lung Cancer Research Studies 5
-
- Cancer therapeutics and mechanisms 5
- DNA Repair Mechanisms 4
- RNA modifications and cancer 3
- Co-authors
- Jonathan R. Brody (9 shared papers)Teena Dhir (6 shared papers)Ranjan Preet (1 shared paper)Dan A. Dixon (2 shared papers)Michael J. Pishvaian (2 shared papers)Anish Thomas (9 shared papers)Avinoam Nevler (5 shared papers)Vinodh N. Rajapakse (5 shared papers)
- Journals
- Molecular Cancer Therapeutics (3 papers)Annals of Surgical Oncology (2 papers)Computational and Structural Biotechnology Journal (1 paper)Biomedicines (1 paper)Journal of the American College of Surgeons (1 paper)
- Partner nations
- United StatesJapanSouth Korea
In The Last Decade
Christopher W. Schultz
22 papers receiving 522 citations
Peers
Comparison fields: 5 of 60
- Oncology 231
- Cancer Research 122
- Molecular Biology 319
- Epidemiology 54
- Pulmonary and Respiratory Medicine 51
Countries citing papers authored by Christopher W. Schultz
This map shows the geographic impact of Christopher W. Schultz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher W. Schultz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher W. Schultz more than expected).
Fields of papers citing papers by Christopher W. Schultz
This network shows the impact of papers produced by Christopher W. Schultz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher W. Schultz. The network helps show where Christopher W. Schultz may publish in the future.
Co-authors
The 25 scholars most cited alongside Christopher W. Schultz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 159 | |
| 2 | 2021 | 76 | |
| 3 | 2022 | 66 | |
| 4 | 2019 | 54 | |
| 5 | 2019 | 46 | |
| 6 | 2022 | 22 | |
| 7 | 2022 | 20 | |
| 8 | 2022 | 11 | |
| 9 | 2022 | 9 | |
| 10 | 2020 | 8 | |
| 11 | 2023 | 7 | |
| 12 | 2020 | 7 | |
| 13 | 2020 | 6 | |
| 14 | 2021 | 6 | |
| 15 | 2023 | 5 | |
| 16 | 2024 | 5 | |
| 17 | 2020 | 4 | |
| 18 | 2025 | 4 | |
| 19 | 2019 | 3 | |
| 20 | 2022 | 2 |
About Christopher W. Schultz
Christopher W. Schultz is a scholar working on Oncology, Molecular Biology, Cancer Research, Pulmonary and Respiratory Medicine and Epidemiology, having authored 23 papers that have together received 522 indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (8 papers), Lung Cancer Research Studies (5 papers), Cancer therapeutics and mechanisms (5 papers), DNA Repair Mechanisms (4 papers), Cancer Genomics and Diagnostics (4 papers), RNA modifications and cancer (3 papers), Neuroendocrine Tumor Research Advances (2 papers) and Advanced Breast Cancer Therapies (2 papers). The work is most often cited by research in Oncology (231 citations), Cancer Research (122 citations), Molecular Biology (319 citations), Epidemiology (54 citations) and Pulmonary and Respiratory Medicine (51 citations). Christopher W. Schultz has collaborated with scholars based in United States, Japan and South Korea. Frequent co-authors include Jonathan R. Brody, Teena Dhir, Ranjan Preet, Dan A. Dixon, Michael J. Pishvaian, Anish Thomas, Avinoam Nevler, Vinodh N. Rajapakse, Samantha Armstrong and Nobuyuki Takahashi. Their work appears in journals such as Molecular Cancer Therapeutics, Annals of Surgical Oncology, Computational and Structural Biotechnology Journal, Biomedicines and Journal of the American College of Surgeons.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.